GL1X · GenesisL1 explorer

Research workbench

VDR COMPLEX

Analyse VDR COMPLEX in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5OW7
Type
protein
Length
251 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Vitamin D3 receptor a; Nuclear receptor coactivator 1
EC
2.3.1.48
UniProt
Q9PTN2, Q15788
Ligands
AYK
Pockets
3 · best druggability 0.87

Structure

x-ray diffraction · 2 distinct chains · 67% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVitamin D3 receptor aprotein24067% helix, 3% strandQ9PTN2
BNuclear receptor coactivator 1 (EC 2.3.1.48)protein1164% helix, 0% strandQ15788

Ligands and binding sites

  • AYK · (3~{S})-3-[(1~{S},3~{a}~{S},4~{E},7~{a}~{S})-7~{a}-methyl-4-[(2~{Z})-2-[(5~{S})-2-methylidene-5-oxidanyl-cyclohexylidene]ethylidene]-2,3,3~{a},5,6,7-hexahydro-1~{H}-inden-1-yl]-3-oxidanyl-~{N}-propan-2-yl-butanamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13050.870.9635AYK
22010.530.7830empty
3610.330.7610empty

Interfaces

1 interface between chains.

  • A–B · 657 Ų buried · 10 hydrogen bonds · protein-protein

Compared structures

  • 5OW7 · VDR complex · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9PTN2 · AlphaFold monomer V2.0 prediction for vitamin D3 receptor a (Q9PTN2) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.